A5054318158- Head and Neck Cancer Studies
- Salivary Gland Tumors Diagnosis and Treatment
- Ear and Head Tumors
- Oral and Maxillofacial Pathology
- Cancer Diagnosis and Treatment
- Head and Neck Surgical Oncology
- Lung Cancer Research Studies
- Lung Cancer Treatments and Mutations
- Esophageal Cancer Research and Treatment
- Oral Health Pathology and Treatment
- Cutaneous Melanoma Detection and Management
- Advanced Radiotherapy Techniques
- Cardiovascular Disease and Adiposity
- Radiomics and Machine Learning in Medical Imaging
- TGF-β signaling in diseases
- Inflammatory Biomarkers in Disease Prognosis
- Palliative Care and End-of-Life Issues
- Prostate Cancer Diagnosis and Treatment
- Electrolyte and hormonal disorders
- Nonmelanoma Skin Cancer Studies
- Thyroid Cancer Diagnosis and Treatment
- Bone Tissue Engineering Materials
- Soft tissue tumors and treatment
- Peptidase Inhibition and Analysis
- Cancer Genomics and Diagnostics
University Hospital Dubrava
2024-2025
University Hospital Centre Zagreb
2014-2021
University of Zagreb
2012-2019
Sisters of Charity Hospital
2016
Zabok General Hospital
2012
Myoepithelial carcinoma (MC) is a rare salivary gland malignancy that usually affects people over the age of 50. The incidence similar in both men and women. MC might develop de novo or within pre-existing benign myoepithelioma pleomorphic adenoma. Reports on clinical behaviour differ. Here, we present case female patient her 60s who had surgery for parotid MC. Seven years after parotidectomy, distant metastasis was found sixth left rib, she underwent metastasectomy. Nine initial surgery,...
Background The aim of this study was to determine the possible predictive value various dosimetric parameters on development hypothyroidism (HT) in patients with head and neck squamous cell carcinoma (HNSCC) treated (chemo)radiotherapy. Patients methods This included 156 HNSCC who were (chemo)radiotherapy a primary or postoperative setting between August 2012 September 2017. Dose-volume as well V10 toV70, D02 D98, VS10 VS70 evaluated. patients' hormone status regularly assessed during...
Head and neck squamous cell carcinoma (HNSCC) is the fifth most common cancer in world. Although multimodal targeted therapy now used therapeutic procedures, survival of patients with HNSCC has remained unchanged over last 30 years. A number studies have demonstrated that increased expression intranuclear ERβ breast, lung colon a favorable prognostic marker associated higher rates. However, clinical significance sex hormone receptors remains unclear. The current study aimed to assess...
The purpose of this study was to identify clinicopathological and immunohistochemical factors predicting delayed lymph node metastases survival in early oral squamous cell carcinoma (OSCC).The included 85 consecutive patients with clinically T1 T2N0 OSCC who were primarily surgically treated between 2000 2004.There 68 men 17 women (median age, 61 years; range, 34-82 years). Of all the patients, 25 (29.4%) developed within 3 42 months after treatment primary tumor. Multivariate logistic...
Abstract Background The purpose of our article was to describe a tertiary center's experience with patients primarily surgically treated early‐stage intraoral cancer second primary malignancy confirmed during follow‐up. Methods A total 183 were for oral between 2000 and 2004. Among these, 24 (13.1% (24/183)) met inclusion criteria. Results There 22 men (91.7%) 2 women (8.3%) median age 59.5 years. Patients head neck had significantly higher survival compared nonhead malignancy. diagnosed the...